Cva Family Office, LLC Laboratory Corp Of America Holdings Transaction History

Cva Family Office, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$197.69 - $227.29 $988 - $1,136	5 New	5 $1,000
Q2 2023 Jul 10, 2023	BUY	$211.93 - $241.33 $1,059 - $1,206	5 New	5 $1,000
Q4 2022 Feb 21, 2023	SELL	$203.72 - $248.97 $7,130 - $8,713	-35 Reduced 87.5%	5 $1,000
Q2 2022 Jul 11, 2022	SELL	$213.86 - $277.87 $1,069 - $1,389	-5 Reduced 11.11%	40 $9,000
Q4 2021 Jan 25, 2022	BUY	$271.6 - $314.21 $12,222 - $14,139	45 New	45 $14,000
Q3 2021 Oct 12, 2021	SELL	$274.82 - $308.34 $12,366 - $13,875	-45 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$251.87 - $278.14 $2,518 - $2,781	10 Added 28.57%	45 $12,000
Q1 2021 Apr 14, 2021	BUY	$204.88 - $255.03 $7,170 - $8,926	35 New	35 $9,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.